No Results Found
Try adjusting your search to find what you’re looking for.
11/05/2025
Illumina and Grail Veterans Launch Hepta With First Liquid Biopsy-Native AI That Detects Liver Disease With Tissue-Level Biological Insights
The company’s transformer model interprets up to one billion DNA fragments in each blood sample, capturing molecular context at a scale hundreds of times greater than leading LLMs and demonstrating strong clinical validation. With $6.7 million seed led by Felicis Ventures and Illumina Ventures, Hepta advances liquid biopsy platforms beyond oncology.
Read More
10/07/2025
Spotlight on Tom Willis, PhD – CEO Arima Genomics October 2025
Spotlight on Tom Willis, PhD – CEO Arima Genomics
Read More
10/01/2025
Predicta Biosciences Secures $23.4M to Scale its Novel Diagnostic and Analytics Platform for Blood Cancers
Predicta Biosciences, a precision oncology company developing novel diagnostic and therapeutic discovery solutions, today announced it has raised an oversubscribed $23.4 million Series A led by Engine Ventures. Additional participating investors include Illumina Ventures.
Read More
9/02/2025
Abhijit “Ron” Mazumder, Ph.D. Partner Illumina Ventures – September 2025
Spotlight on Abhijit “Ron” Mazumder, Ph.D. - Partner Illumina Ventures
Read More
